Unknown

Dataset Information

0

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.

ABSTRACT:

SUBMITTER: Greenberger LM 

PROVIDER: S-EPMC8295014 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.

Greenberger Lee M LM   Saltzman Larry A LA   Senefeld Jonathon W JW   Johnson Patrick W PW   DeGennaro Louis J LJ   Nichols Gwen L GL  

Cancer cell 20210722 8

Similar Datasets

Unknown Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies.
| S-EPMC9894565 | biostudies-literature
Unknown Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies.
| S-EPMC8421105 | biostudies-literature
Unknown Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients.
| S-EPMC8394831 | biostudies-literature
Unknown Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
| S-EPMC9662771 | biostudies-literature
Unknown Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
| S-EPMC8353615 | biostudies-literature
Unknown COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
| S-EPMC8444788 | biostudies-literature
Unknown Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
| S-EPMC9108069 | biostudies-literature
Unknown Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
| S-EPMC8982368 | biostudies-literature
Unknown Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies
| S-EPMC10928260 | biostudies-literature
Unknown Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies.
| S-EPMC8632354 | biostudies-literature